Search clinical trials for: dabrafenib and trametinib
Total 271566 results
-
Shandong UniversityNot yet recruiting
-
National Cancer Centre, SingaporeRecruitingColorectal Cancer | Pancreatic AdenocarcinomaSingapore
-
University of CologneCompletedBronchial NeoplasmsSpain, Germany
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Clovis Oncology, Inc.Novartis PharmaceuticalsTerminated
-
GlaxoSmithKlineCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis; National Comprehensive Cancer NetworkCompletedCholangiocarcinoma | Soft-tissue Sarcoma | Solid Tumors | Thyroid CancerUnited States
-
GlaxoSmithKlineCompleted
-
The Netherlands Cancer InstituteBristol-Myers Squibb; Eli Lilly and Company; Bayer; GlaxoSmithKline; Merck Sharp... and other collaboratorsRecruitingCancer | Neoplasm | Tumors | NeoplasiaNetherlands
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Collin BlakelyNovartisRecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingMelanomaItaly, Belgium, Germany, Argentina, Australia, France, Israel, Netherlands, Switzerland, United States, United Kingdom, Norway
-
C4 Therapeutics, Inc.RecruitingMelanoma | NSCLC | Solid Tumors | CRC | ATCUnited States, Spain, France
-
Novartis PharmaceuticalsTerminatedMelanoma | Non-Small Cell Lung CancerItaly, Australia, Belgium, Germany, Spain, Korea, Republic of, Israel, France, United States, Sweden, Poland
-
University of California, San FranciscoNovartis Pharmaceuticals; University of California, DavisTerminatedNon-small Cell Lung CancerUnited States
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingHepatocellular Carcinoma | Solid Tumor, AdultChina
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
GlaxoSmithKlineCompletedCancerUnited States, Korea, Republic of, Canada, France
-
GlaxoSmithKlineCompletedCancerAustralia, Spain, United States, Germany, Poland, Italy, Canada, Ireland, Hungary, Russian Federation, Netherlands, France
-
University Health Network, TorontoCompletedColorectal Cancer | KRAS Wildtype | NRAS Wildtype | BRAF WildtypeCanada
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedLiver Cancer | Hepatocellular CancerUnited States
-
Erasca, Inc.RecruitingAdvanced or Metastatic Solid TumorsUnited States, Korea, Republic of, Canada, United Kingdom, Australia
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
University of ArkansasWithdrawn
-
Peter Hosein, MDNovartis Pharmaceuticals; Incyte Corporation; University of Miami Sylvester Comprehensive...RecruitingPancreatic Ductal AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterNovartis; AstraZeneca; MedImmune LLCCompletedColorectal Cancer | Colon Cancer | Malignant Neoplasms of Digestive OrgansUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsActive, not recruitingMelanoma | Unresectable Melanoma | Advanced MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedLung Cancer | Lung Cancer Metastatic | Lung Adenocarcinoma | Lung Cancer Stage IV | Recurrent Lung Adenocarcinoma | Recurrent Lung CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Liver | Unresectable Solid NeoplasmUnited States, Canada
-
Deciphera Pharmaceuticals LLCRecruitingMelanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Pancreatic Ductal AdenocarcinomaUnited States
-
Rigel PharmaceuticalsCompletedRheumatoid ArthritisUnited States, Mexico
-
Yabao Pharmaceutical GroupCompleted
-
University Hospital, Strasbourg, FranceRecruitingPleomorphic Xanthoastrocytoma | Grade 1 Glioma | Mixed Glio-neuronal TumorsFrance
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, Spain, Korea, Republic of, Netherlands, Greece, France, Italy, Hungary
-
Memorial Sloan Kettering Cancer CenterNovartisActive, not recruitingAnaplastic Thyroid CancerUnited States
-
National Cancer Institute (NCI)CompletedLocally Advanced Epithelioid Hemangioendothelioma | Metastatic Epithelioid Hemangioendothelioma | Unresectable Epithelioid HemangioendotheliomaUnited States
-
National Cancer Institute (NCI)Glaxosmithkline Biologicals S.A.TerminatedRenal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic ComplicationUnited States, Canada
-
GlaxoSmithKlineWithdrawn
-
Cancer Trials IrelandNovartisRecruiting
-
GlaxoSmithKlineCompletedCancerUnited States, France
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingJuvenile Myelomonocytic Leukemia | Neurofibromatosis Type 1United States
-
National Cancer Institute (NCI)TerminatedCholangiocarcinoma | Bile Duct Cancer | Biliary Tract Neoplasms | Biliary CancerUnited States
-
GlaxoSmithKlineCompletedCancerSpain, United States
-
Alzheimer's Disease Cooperative Study (ADCS)National Institute on Aging (NIA); Alzheimer's Association; VA Puget Sound Health...CompletedAlzheimer's Disease | Disruptive BehaviorUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedEndometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States
-
Kyowa Kirin Pharmaceutical Development LtdCompletedChemotherapy Induced Nausea and VomitingUnited States
-
Jonsson Comprehensive Cancer CenterNovartis; Stand Up To Cancer; Prostate Cancer FoundationActive, not recruitingMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
National Cancer Institute (NCI)CompletedStage IV Uveal Melanoma AJCC v7 | Recurrent Uveal MelanomaUnited States, France, United Kingdom
-
GlaxoSmithKlineCompleted